The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg.

The Food and Drug Administration approved a higher dose version of Novo Nordisk's blockbuster weight loss injection Wegovy, as the company pushes to win back market share from Eli Lilly. The high-dose ...

March 19 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Thursday the U.S. Food and Drug Administration has approved a higher dose of its blockbuster weight-loss drug Wegovy. The ...

Many challenges face developers of drugs for rare diseases, including the small number of patients available for clinical trials, genotypic and phenotypic diversity within a disorder, poorly ...

Please provide your email address to receive an email when new articles are posted on . A revised technosphere insulin label recommends patients start using the therapy at a higher dose than ...

The IAEA has released comprehensive guidance on dose management systems — software tools that collect, monitor and analyse patient data on radiation doses. This new resource will help medical ...

Drug-induced fever is commonly misdiagnosed, particularly in cases of suspected or confirmed infection. A 21-year-old woman developed trimethoprim-sulfamethoxazole-induced fever, confirmed by a ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Earlier this year, my wife and I welcomed our son ...

Now, before I get into it, I will preface this review by saying my liver was fine to begin with. And if my liver were to give me issues, I would go to a doctor (as you should too!) before ever turning ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Credit: Getty Images. Over the course of the patient's treatment, there were opportunities to recognize the error and prevent the patient's catastrophic results. The ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...